Cancer diagnosis

Cancer research

Breakthrough in Cancer Biomarker Detection: Nanopore-based ELISA Shows High Sensitivity

Researchers from the Chinese People's Liberation Army (PLA) General Hospital have made a significant discovery in cancer diagnostics, developing an enzyme-linked immunosorbent assay (ELISA) that uses nanotechnology to detect cancer biomarkers with unprecedented sensitivity. This novel approach has the potential to revolutionize cancer diagnosis and point-of-care testing. According